Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Prepaid Assets (2021 - 2025)

Verrica Pharmaceuticals has reported Prepaid Assets over the past 5 years, most recently at $2.8 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $2.8 million for Q4 2025, up 21.26% from a year ago — trailing twelve months through Dec 2025 was $2.8 million (up 21.26% YoY), and the annual figure for FY2025 was $2.8 million, up 21.26%.
  • Prepaid Assets for Q4 2025 was $2.8 million at Verrica Pharmaceuticals, down from $3.6 million in the prior quarter.
  • Over the last five years, Prepaid Assets for VRCA hit a ceiling of $4.4 million in Q4 2022 and a floor of $1.5 million in Q2 2023.
  • Median Prepaid Assets over the past 5 years was $2.8 million (2021), compared with a mean of $2.9 million.
  • Biggest five-year swings in Prepaid Assets: plummeted 46.28% in 2023 and later soared 69.13% in 2024.
  • Verrica Pharmaceuticals' Prepaid Assets stood at $4.0 million in 2021, then increased by 9.59% to $4.4 million in 2022, then plummeted by 41.56% to $2.5 million in 2023, then fell by 9.23% to $2.3 million in 2024, then increased by 21.26% to $2.8 million in 2025.
  • The last three reported values for Prepaid Assets were $2.8 million (Q4 2025), $3.6 million (Q3 2025), and $1.5 million (Q2 2025) per Business Quant data.